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Despite many studies documenting the prevalence of various co-occurring psychiatric
symptoms in children and adults with ASD, less is known about how these symptoms
relate to subtypes defined by particular phenotypic features within the ASD population.
We examined the severity and prevalence of comorbid symptoms of psychopathology,
emotion dysregulation, and maladaptive behaviors, as well as adaptive functioning, in a
group of 65 minimally verbal children (n = 33) and adolescents (n =32) with ASD. On the
Child and Adolescent Symptom Inventory (CASI-5), for all the symptom classifications
except oppositional defiant disorder and conduct disorder, more participants in our
sample showed elevated or clinically concerning severity scores relative to the general
population. On the Emotion Dysregulation Inventory (EDI), the mean scores for Reactivity
and Dysphoria factors in our sample were lower than in the autism calibration sample,
which included a large number of inpatient youth with ASD. Overall, few differences
were found between the children and adolescents within this severely impaired group
of ASD individuals based on clinical cutoff scores on the CASI-5 and EDI factor scores.
Psychiatric comorbidities and emotion dysregulation measures were not correlated with
autism symptom severity or with measures of adaptive functioning, and were largely
unrelated to IQ in our sample. The number of clinically significant psychiatric symptoms
on the CASI-5 emerged as the main predictor of maladaptive behaviors. Findings
suggest a wide range of co-occurring psychopathology and high degree of maladaptive
behavior among minimally verbal children and adolescents with ASD, which are not
directly attributable to autism symptom severity, intellectual disability or limitations in
adaptive functioning.
Keywords: psychopathology, minimally verbal autism spectrum disorder, maladaptive behavior, children,
adolescents
INTRODUCTION
Interest in the presence of comorbid conditions in individuals with autism spectrum disorder
(ASD) has increased considerably in recent years, particularly in research aimed at characterizing
the substantial phenotypic heterogeneity found in ASD and its possible underlying etiology (1–4).
Whilemany studies have documented the prevalence of various co-occurring psychiatric symptoms
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in children and adults with ASD, little is known about how
these symptoms relate to specific phenotypic characteristics, such
as expressive language ability, which varies significantly among
individuals with ASD (5). When researchers have focused on
particular subgroups of individuals with ASD, they were typically
distinguished by the presence or absence of intellectual disability
(ID), without explicit consideration of the ability to use spoken
language functionally.
The majority of these studies have indicated a higher
prevalence and number of different psychiatric conditions in
youth with ASD compared to age-matched control groups
without ASD (2, 6, 7), however the reported prevalence of these
conditions has varied across studies. In a literature review of
existing research on comorbid conditions in individuals with
ASD, Mannion and Leader (2) attributed inconsistent findings
to the use of different instruments, and differences in study
participants’ intellectual and communication abilities, among
other factors (8–10). For instance, rates of anxiety in individuals
with ASD have been estimated between 11 and 84% (11, 12), and
rates of ADHD co-occurring with ASD have varied between 28
and 87% (13–15). The inconsistencies in findings across studies
could be related to the diagnostic instruments commonly used to
characterize psychiatric and behavior dysregulation symptoms in
children and adults, which have not been specifically designed to
screen for comorbid psychopathology in people with ASD [e.g.,
the Aberrant Behavior Checklist, ABC; (16, 17); Child Behavior
Checklist, CBCL; (18); CASI-5; (19)].
Several studies have employed instruments specifically
designed for use with adults with ASD [e.g., Autism Spectrum
Disorders—Comorbidity for Adults, ASD-CA; (20)] or children
with ASD [e.g., Baby and Infant Screen for Children with
Autism Traits; BISCUIT; (21); Autism Comorbidity Interview-
Present and Lifetime; ACI-PL; (22); Autism Spectrum Disorders-
Comorbidity for Children, ASD-CC; (23, 24)]. Using the
Autism Comorbidity Interview [ACI-PL; (22)], which was
developed based on an adaptation of the Kiddie-Schedule
for Affective Disorders and Schizophrenia [K-SADS; (25)],
Leyfer et al. (22) found that the most prevalent psychiatric
comorbidity in a sample of verbal 5-to-17-year-olds was specific
phobia, present in 44% of the sample, followed by obsessive-
compulsive disorder (OCD) present in 37% of the sample. In
contrast, Simonoff et al. (14) reported that only 8% of their
sample had a diagnosis of OCD, while the most prevalent
psychiatric comorbidity was social anxiety (29%), followed by
ADHD (28%) in their ASD sample between the ages of 11
and 14 years, most of whom had IQ scores over 70. The
utility of these measures for assessing psychiatric comorbidities
in non- or minimally verbal (MV) individuals with ASD,
many of whom also have intellectual disability, is not clear,
given that these studies enrolled primarily individuals with
spoken language.
Thus, despite interest in the comorbid psychiatric conditions
in people with ASD, there is a paucity of studies that focus on
the segment of the population most severely affected, the ∼30%
of individuals with ASD who remain non- or minimally verbal
beyond school-age (26, 27). In an effort to fill this gap, a research
collaborative between several academic and medical institutions
was established in 2014, with the goal of conducting common
comprehensive assessments on children and adolescents with
ASD admitted to inpatient psychiatry care units [the Autism
Inpatient Collection; AIC; (28)]. A preliminary paper reporting
on 147 participants showed that expressive language impairment
(being non-, or minimally verbal) affected 52% of the sample,
43% had intellectual disability, and 27% engaged in self-injurious
behavior. Elevated behavioral disturbance was common in this
cohort as reflected by high average scores on the Irritability
and Hyperactivity subscales of the Aberrant Behavior Checklist
[ABC; (16)], which are indicative of clinically concerning
externalizing symptoms (4).
A second paper based in part on the same sample (29)
directly compared 165 minimally verbal individuals with ASD
with a cohort of 268 verbal youth with ASD, drawn from several
referral sources, mostly outpatient clinics, on the Child and
Adolescent Symptom Inventory [CASI-4 and−5; (19, 30)] parent-
report rating scales. The main findings were that, regardless
of verbal ability status, inpatient participants showed greater
severity and were more likely to exceed clinical cutoffs than those
in outpatient settings across almost all CASI-4 and−5 psychiatric
classifications. However, in comparisons between the minimally
verbal and verbal groups, the verbal group had higher symptom
severity, and a higher percentage of participants exceeded clinical
cut-offs for depression, general anxiety disorder and oppositional
defiant disorder. These results were consistent with other reports
in the literature that have suggested that better functional
communication was associated with higher levels of anxiety in
individuals with ASD (31–34), although these other studies did
not specifically enroll or investigate minimally verbal individuals
with ASD as a group. In contrast to the profile of psychiatric
comorbidities reported for verbal individuals with ASD, the
MV participants assessed by Lerner et al. (29) were more likely
to meet the clinical cutoff for ADHD-Hyperactivity/Impulsivity
type relative to the verbal participants (50% compared to 37%),
when controlling for non-verbal IQ, age, and ADOS calibrated
symptom severity scores.
In sum, the majority of previous studies did not enroll
non- or minimally verbal youths with ASD and only more
recent studies have focused specifically on this neglected
“severe end of the spectrum” (26, 28). Expanding on this
research, here we examined the type, frequency, and severity of
psychiatric symptoms using the CASI-5 as our primary outcome
measure, and the Emotion Dysregulation Inventory [EDI; (35)],
a new measure designed to assess emotion control difficulties
independently of IQ and verbal ability in individuals with ASD,
in a group of MV children and adolescents with ASD who have
never received inpatient psychiatric care. Given that emotion
dysregulation has been proposed as one potential explanatory
mechanism for the high rates of psychiatric comorbidities found
among individuals with ASD (36), we hypothesized that the
EDI reactivity and dysphoria scales would be correlated with
several of the CASI-5 symptom classifications indicative of
externalizing and internalizing disorders, respectively. Because
minimal capacity for spoken language is often associated with
intellectual disability (ID) in ASD, we examined whether CASI-5
psychiatric comorbidities and EDI reactivity and dysphoria were
associated with maladaptive behaviors in our MV-ASD sample,
independently of age and ID.
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The overarching aim of our study was to characterize the
profile of comorbid symptoms of psychopathology and emotion
dysregulation in an exclusively outpatient sample of children
and adolescents who remained minimally verbal by school age
(5 years and older). In particular, based on CASI-5 scores, we
examined the severity and frequency of psychiatric symptoms
in 5-to-18-year-old children and adolescents with ASD, relative
to population norms. In addition, based on EDI scores, we
investigated the frequency of parent-reported symptoms of
emotional reactivity and dysphoria.
The specific goals of this study were:
1) To investigate whether individual differences, such as
age and gender, influence the presentation of psychiatric
comorbidities and emotion dysregulation among MV
individuals with ASD. In particular, we examined whether
children (5; 0 to 11; 11 years) differed from adolescents
(12; 1 to 18; 6 years) in the type, prevalence and severity of
symptoms reported by caregivers on the CASI-5 and EDI;
2) To examine the relationships between ratings of psychiatric
symptoms and of emotion dysregulation and other
characteristics of the sample, such as cognitive ability
(IQ), adaptive functioning, maladaptive behavior, and autism
symptom severity.
3) To examine whether the overall burden of psychiatric
comorbidities and emotion dysregulation predict maladaptive
behaviors, over and above variability in IQ and age, in MV
individuals with ASD.
METHODS
Participants
Sixty-five participants diagnosed with ASD who had limited
verbal abilities (i.e., few to no words used spontaneously)
were included in the study. Participants had enrolled in a
larger phenotyping study of minimally verbal (MV) individuals
with ASD conducted at a University-affiliated research center.
They were recruited from a variety of resources in the
community including schools, clinics, and social media and
came from predominantly English-speaking homes, had normal
or corrected-to-normal vision and hearing, and did not have
significant neurological impairment. Based on a medical history
survey answered by caregivers, none of the participants had ever
been hospitalized in a psychiatric care unit prior to participation
in our research. Informed consent was obtained from the parents,
and the Boston University Institutional Review Board approved
study procedures.
ASD diagnoses of the children and adolescents enrolled in the
study were confirmed using the Autism Diagnostic Interview—
Revised [ADI-R; (37)] conducted with primary caregivers and
the ADOS. Participants aged 5 through 11 years (n = 33) were
assessed with Module 1 of the Autism Diagnostic Observation
Schedule-2 [ADOS-2; (38)]. Participants aged 12 through 18
years (n= 32) were assessed withModule 1 of the Adapted ADOS
[A-ADOS; (39)], which uses play materials more appropriate and
engaging for adolescents. The ADOS Module 1 was specifically
designed to assess ASD symptomatology in children with few to
no words and is therefore appropriate for defining minimally
verbal ASD (40). Social-affective and restrictive and repetitive
behavior symptom severity were calculated with the ADOS
calibrated symptom severity scores, which are comparable
across ADOS modules (41). For both the ADI-R and the
ADOS assessments, higher diagnostic algorithm and calibrated
symptom severity scores indicate more severe ASD symptoms.
Participant characteristics are reported in Tables 1A, 1B by
age group.
Measures and Procedure
All participants were administered a battery of cognitive
diagnostic assessments and parents completed several
questionnaires and interviews about their child’s developmental
history and current behavioral profile, either in their homes, or
when their child was being tested.
Measures of Cognitive and Adaptive
Functioning
Non-verbal IQ (NVIQ) was assessed with the Leiter International
Performance Scale -Third Edition [Leiter-3; (42)], a test
commonly used with minimally- and low-verbal individuals with
ASD (43) because it does not require verbal instructions or verbal
responding. Parents completed the Vineland Adaptive Behavior
Scales, Second Edition [VABS-II; (44)], a measure administered
in a semi-structured interview format. In addition to assessing
the level of an individual’s personal and social skills required
for everyday living, the VABS-II also yields a maladaptive
TABLE 1A | Participant characteristics, by age group.
Child Adolescent pa
N = 33 N = 32
Mean (SD) Mean (SD)
Age 7.59 (1.99) 14.79 (1.9) 0.001
ADI-R SCORES
Social interaction 25.94 (2.72) 26.04 (3.8) ns
Nonverbal communication 11.9 (2.22) 12.59 (1.53) ns
Repetitive behaviors 5.35 (1.49) 5.96 (2.47) ns
ADOS SYMPTOM SEVERITY SCORES
Social affect 7.12 (1.19) 7.47 (1.74) ns
Restricted and repetitive behaviors 8.91 (1.18) 7.94 (1.70) 0.009
Total (overall CSS) 7. 70 (1.18) 7.59 (1.74) ns
Leiter-3 nonverbal IQ 70.53 (14.69) 48.97(12.97) 0.001
VINELAND ADAPTIVE BEHAVIOR SCALES (VABS–II)b
Communication domain 54.91 (12.26) 43.39 (9.74) 0.001
Socialization domain 55.66 (8.27) 43.85 (6.37) 0.001
Daily living skills 62.0 (10.38) 50.48 (11.02) 0.001
Adaptive behavior composite 57.13 (8.88) 44.54 (9.18) 0.001
Maladaptive behavior indexc 19.25 (1.54) 19.14 (1.18) ns
Internalizing behaviorsc 19.38 (2.03) 19.64 (1.50) ns
Externalizing behaviorsc 17.28 (1.81) 17.79 (1.55) ns
a Independent-samples t-test.
b Data on VABS-II was not available for 4 adolescent participants.
c v-Scale scores.
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TABLE 1B | Demographic characteristics of the participants.
Child Adolescent Pa
N = 33 N = 32
Mean (SD) Mean (SD)
Gender (Male/Female) 27/6 22/10 ns
Race/Ethnicity ns
White 60.6% 68.8%
Hispanic 6.0% 3.1%
Native Hawaiian/Pacific islander 0 3.1%
More than one race / unknown 9.1% 3.1%
Maternal education ns
Less than high school 0 0
High school/GED 6.0% 6.2%
Some college 27.3% 19.4%
Bachelor’s degree 18.2% 35. 5%
Graduate degree 45.4% 32.3%
Other (e.g., trade vocational school) 3% 6.5%
Household income ns
< $50,000.00 12.12% 6.25%
$50,000 to $100,000 12.12% 6.25%
>$100,000.00 48.5% 53.13%
No response 27.3% 34.37%
aχ2 test.
behaviors index (including separate scores for externalizing and
internalizing maladaptive behaviors), based on caregiver ratings
of problematic or challenging behaviors that interfere with a
person’s optimal daily functioning.
Parent-Report Measures of Comorbid
Psychopathology and Emotion
Dysregulation
Child and Adolescent Symptom Inventory (CASI-5)
We used the parent-report version of the CASI-5 to examine
the frequency and severity of comorbid psychiatric symptoms
in our sample. The parent version of the CASI-5 includes 173
items, which rate behaviors as occurring never, sometimes, often
and very often. The items assess symptoms of DSM-5 psychiatric
disorders, including Attention Deficit Hyperactivity Disorder
(inattentive, hyperactive/impulsive, & combined types), anxiety
disorders (generalized anxiety, social anxiety/’social phobia’, and
separation anxiety), conduct disorder and oppositional-defiant
disorder, mood disorders (major depressive episode, dysthymia,
and manic episode) and eating disorders (anorexia, bulimia).
In addition, a limited number of symptoms characteristic
of the following disorders are also included: posttraumatic
stress disorder, obsessive-compulsive disorder, schizophrenia and
schizoid personality, specific phobia, panic disorder, selective
mutism, trichotillomania, motor tics, vocal tics, and substance
use. For the majority of items, symptoms rated as occurring often
and very often are considered clinically significant, and those
rated as never or sometimes are not.
The CASI-5 yields several types of scores that correspond to
two approaches to assessing psychiatric symptomatology. One
approach is based on a dimensional scoring method that uses
normative data to generate T-scores (with a mean of 50 and SD
= 10) for each symptom classification based on the participant’s
gender and age. For the purposes of this study, we considered
severity T-scores > 65 (i.e., > 1.5 SD above the mean and at the
93rd percentile or higher relative to the norm sample) as clinically
and functionally significant. The second approach to scoring
is categorical and involves determining whether an individual
meets criteria for a particular DSM-5 screening diagnosis based
on the number of clinically concerning symptoms shown (e.g.,
items rated often and very often); this number—labeled Symptom
Count Score—is compared to a Symptom Count Cutoff /criterion
score for each disorder classification. It should be noted that
symptom count cutoff scores do not indicate a psychiatric
diagnosis, and their relevance is restricted to screening purposes
for clinically concerning symptoms related to a specific disorder.
According to recent reviews [e.g., (45)], the CASI-5 subscale
scores generally show a high degree of correspondence with
psychiatric diagnoses (predictive validity) and correlate well
with other commonly used dimensional scales (concurrent
validity), demonstrating satisfactory psychometric properties for
a diversity of youth, including those with ASD (30).
Emotion Dysregulation Inventory (EDI)
Emotion dysregulation was assessed with the 66-item version of
the EDI, a caregiver-report questionnaire designed to capture
emotional distress and a wide range of problems with emotion
regulation in youth with ASD ages 6 years and above. The items
describe observable indicators of poor emotion regulation, which
are rated by caregivers on a 0 to 4 scale from “not at all—never
happens” to “very severe—almost always happening and causes a
serious problem.” The EDI is comprised of two scales: a Reactivity
scale, which captures intense, rapidly escalating, sustained, and
poorly regulated negative emotional reactions, and a Dysphoria
scale, characterized by minimal positive affect and motivation,
and the presence of nervousness and sadness. The EDI reactivity
and dysphoria scales yield raw scores that were converted into T-
scores based on tables provided to us by the instrument’s author.
It should be noted that the calibration sample for this instrument
consisted of a large combined sample of 1,751 community and
psychiatric inpatients with ASD. Therefore, the results we present
are relative to the autism norms and scoring that were validated
for this population (36).
Statistical Analysis
Descriptive statistics were calculated using means and standard
deviations for continuous variables and frequencies and
proportions for categorical variables. First, children and
adolescent groups were compared on demographic variables,
including scores on standardized tests of cognitive and adaptive
functioning and autism symptom severity, using independent
sample t-tests or χ2 tests, as appropriate. Variables on which
significant group differences were found (e.g., NVIQ) were
controlled for (entered as covariates) in analyses of the CASI-5
and EDI factors variables, conducted to compare psychiatric
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comorbidities and emotion dysregulation ratings across the
age groups.
We conducted several types of analyses of the CASI-5 parent
ratings to characterize the profile of psychiatric comorbidities in
our sample. First, we examined the prevalence of different types
of comorbidities based on the frequencies of scores exceeding the
clinical cut-off for each CASI-5 classification (categorical scoring
approach). Then we explored the distribution of clinically
significant CASI-5 symptom severity scores (i.e., T-score > 65)
in our sample relative to the distribution expected in the general
population, usingχ2 to test for significant differences.We further
examined age and gender group differences in the severity of
comorbid symptoms (dimensional scoring) using a multivariate
analysis of variance approach with the CASI-5 T-scores as the
dependent variables, while co-varying NVIQ. More specifically,
the continuous CASI-5 symptom severity variables (T-scores) for
the psychiatric classifications relevant for both age groups (nine
classifications or subscales) were entered into a multivariate
analysis of covariance (MANCOVA) to determine if symptom
severity-scores across classifications differed as a function of
age-group and gender, after controlling for NVIQ. To further
examine group differences, the multivariate test was followed
by univariate ANOVAs and post-hoc tests, as needed, using
Bonferroni corrected significance levels. A similar MANCOVA
was conducted with the two EDI factors as dependent variables,
age-group and gender as between-subjects factors and NVIQ
as a covariate, to examine possible group differences in aspects
of emotion dysregulation, after controlling for cognitive ability.
Relationships between psychiatric comorbidities, emotion
dysregulation factors and level of cognitive functioning
(NVIQ), were examined using Pearson correlations. We
further investigated relationships between selected psychiatric
comorbidities, emotion dysregulation factors, autism symptom
severity and ratings of maladaptive behavior on the VABS-II
while controlling for NVIQ, using partial correlations and
the Holm-Bonferroni method to correct for multiple testing.
Finally, to investigate if psychiatric comorbidities or emotion
dysregulation factors contributed significantly to ratings of
maladaptive behavior on the VABS-II, a stepwise multiple
regression analysis was conducted, entering age and NVIQ on
the first step, followed by the number of clinically significant
comorbidities endorsed by parents on the CASI-5 and the
two EDI emotion dysregulation factors as an independent
variables, with VABS-II Maladaptive behavior index scores as the
dependent variable.
RESULTS
Tables 1A,B present demographic characteristics of the
participants, by age group. No differences were found between
males and females on any characteristic listed. The child and
adolescent groups did not differ in gender, race/ethnicity, parent
education, and household income distributions (based on χ2
tests, all p > 0.25), or on ADI-R or ADOS overall calibrated
symptom severity scores. Independent-samples t-tests showed
that younger participants obtained, on average, higher standard
scores on several measures of cognitive and adaptive functioning
than the adolescent group (see Table 1A). Non-verbal IQ and
VABS-II Adaptive Behavior Composite scores were highly
correlated (r = 0.782, p < 0.0001), even when adjusting for age
differences (rp = 0.649, p < 0.0001). Therefore, all analyses of
group differences on the variables of interest from the CASI-5
and the EDI survey were conducted co-varying NVIQ.
Sample Characterization With the CASI-5
Table 2 presents the prevalence of different psychiatric
comorbidities in our sample for children and adolescents,
based on the CASI-5 categorical scoring, which takes into
account whether an individual meets criteria for a particular
DSM-5 diagnosis based on the number of clinically concerning
symptoms shown (i.e., exceeds a Symptom Count Cutoff criterion
for a particular CASI-5 classification). All participants met cutoff
criteria for at least one CASI-5 classification, and the number of
categorical classifications parents endorsed ranged from 1 to 15,
with a mode and a median of 6 classifications. Figure 1 shows
TABLE 2 | Prevalence of participants meeting clinical cut-off scores on CASI-5
symptom classifications.
N Children Adolescents Entire sample
33 32 65
% of sample % of sample % of sample
EXTERNALIZING DISORDERS
ADHD
Inattentive type 48.5 31.25 40
Hyperactive/impulsive type 21.21 25 23.1
Combined type 18.18 18.75 18.5
Oppositional defiant disorder 3.03 3.13 3.1
Conduct disorder 3.03 6.25 4.6
INTERNALIZING DISORDERS
Generalized anxiety disorder 3.03 3.13 3.1
Major depressive disorder 0 3.13 1.5
Dysthymic disorder 3.03 3.13 3.1
Social phobia/social anxiety 12.12 6.2 9.2
Separation anxiety disorder 3.03 3.03 3.1
OTHER DISORDERS
Specific phobia 45.5 40.6 43.1
Panic disorder 0 0 0
Obsessions 6.06 3.13 4.6
Compulsions 36.4 31.25 33.8
Posttraumatic stress 15.2 12.5 13.8
Motor tics 42.4 50 46.2
Vocal tics 54.6 78.13 66.2
Somatic symptoms 3.03 0 1.5
Enuresis 60.6 6.06 52.3
Anorexia nervosa 3.03 3.13 3.1
Bulimia nervosa 6.06 25 15.4
Schizoid personality disorder 12.1 28.1 20
Schizophrenia 0 0 0
Bipolar disorder/Manic episode 3.03 3.13 3.1
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FIGURE 1 | Frequency of participants by number of CASI−5 symptom classifications with clinically significant ratings. Number of psychiatric comorbidities exceeding
clinical cutoff scores.
the distribution of participants by the number of symptom
classifications on which they met clinical cutoff criteria on
the CASI-5.
The most frequent symptom classification endorsed by
parents in our sample was vocal tics, with 66.2% of the sample
meeting clinical cutoff. Forty-six percent of the sample met the
clinical cutoff formotor tics, followed by specific phobia, reported
to be present in 43% of the sample. A large proportion of the
sample met the clinical cutoff for ADHD Inattentive type (40%),
whereas 23% met clinical cutoff for the ADHD Hyperactive-
impulsive type, followed by ADHD Combined type (18.5%).
Compulsions were reported in about a third of the sample.
However, except for vocal tics, no single psychiatric symptom
was found significantly elevated in more than 50% of the sample,
reflecting the wide variety and complex combinations of clinically
significant psychiatric symptoms among our MV participants.
The one exception was enuresis, which was reported for 60.6%
of children but only for 6% of adolescents, suggesting that this
comorbid condition is likely to resolve over time.
We also characterized the profile of psychiatric comorbidities
in this population based on analyses of symptom severity,
afforded by the dimensional scoring approach for the CASI-5
classifications. Symptom severity scores on the CASI-5 indicate
whether an individual shows symptom levels of clinical concern,
even if not having the number of symptoms required to
screen positive for a DSM-5 psychiatric diagnosis. Therefore,
we examined the distribution of T-scores in our sample, taking
as a threshold for clinical significance T-scores higher than 1.5
standard deviation from themean (i.e.,T-scores of 65 and above).
Table 3 shows the percentage of participants who obtained T-
scores above and below 65. When comparing this distribution of
scores to the normal distribution, we found that for all symptom
categories, except oppositional defiant disorder and conduct
disorder, more participants showed clinically concerning severity
scores than expected based on general population norms.
Symptom severity ratings of psychiatric comorbidities (CASI-
5 T-scores) for the 9 symptom classifications common to children
and adolescents (see Table 4) were entered into a MANCOVA
with age-group and gender as between-subjects factors and
NVIQ as covariate. This analysis yielded a significantmultivariate
effect of age group, F(9,51) = 3.291, p = 0.003, Wilks’ 3 =
0.633, partial η2 = 0.367, with no other significant effects
or interactions. Follow-up univariate ANOVAs indicated that
children and adolescents differed significantly in the severity
of their symptoms for ADHD Inattentive type, F(1,59) = 7.10,
p = 0.01, partial η2 = 0.11, with the children showing more
impairment than the adolescents (mean = 67.9, SD = 14.9 vs.
mean = 63.7, SD = 12.3, respectively) and on Major depressive
episode, F(1,59) = 6.32, p = 0.015, partial η
2 = 0.10, with
the adolescents (mean = 61.97, SD = 13.6) showing more
impairment than the children (mean = 52.06, SD = 9.9) in this
category of psychiatric comorbidity.
Sample Characterization on the EDI
Table 5 presents the T-scores for the children and adolescents
in our sample on the EDI reactivity and dysphoria scales.
A MANCOVA with EDI reactivity and dysphoria T-scores as
dependent variables, age-group and gender as between-subjects
factors, and NVIQ as a covariate did not yield any main effects or
interactions indicating that, in our sample, severity of emotion
dysregulation was largely independent of age-group, [F2,49 =
1.54, p = 0.224, Wilks’ 3 = 0.941, partial η2 = 0.06], gender
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TABLE 3 | Proportion of participants (%) by Distribution of clinically significant
T-scores on the CASI-5.
T-score <65 >65 χ2 p
Normal distribution % 93% 7%
EXTERNALIZING DISORDERS
ADHD
Inattentive type 55.4 44.6 141.3, 0.0001
Hyperactive/impulsive type 52.3 47.7 165.3, 0.0001
Combined type 44.6 55.4 233.7, 0.0001
Oppositional defiant disorder 96.9 3.1 1.54, ns
Conduct disorder 96.9 3.1 1.54, ns
INTERNALIZING DISORDERS
Generalized anxiety disorder 72.3 27.7 42.75, 0.0001
Depressive disorders
Major depressive disorder 80 20 16.87, 0.0001
Dysthymic disorder 83.1 16.9 9.83, 0.002
Social phobiaa 72.1 27.9 28.9, 0.0001
Separation anxiety disorder 84.6 15.4 7.02, 0.008
OTHER DISORDERSb
Schizophrenia 58.6 41.4 52.6, 0.0001
Schizoid personality disorder 38.7 61.3 140.4, 0.0001
Bipolar disorder/Manic episode 81.3 18.8 6.79, 0.009
aClassification T-score applies only to children (5–12 years).
bClassification T-scores apply only to adolescents (12–18 years).
[F2,49 = 0.953, p = 0.392, Wilks’ 3 = 0.963, partial η
2 =
0.037], or NVIQ [F2,49 = 0.761, p = 0.473, Wilks’ 3 = 0.796,
partial η2 = 0.03].
Overall, relative to the normative autism calibration sample,
the participants in this study did not show significantly elevated
symptoms of reactivity or dysphoria on the EDI, according
to parent report for current behaviors. The range of T-scores
was 30 to 60 for reactivity and 36 to 58 for dysphoria in our
sample, suggesting that few caregivers rated behaviors indicative
of emotion dysregulation as very severe problems, although across
participants the full scale (0 to 4) was used for most items. Some
items included in the dysphoria scale, however, never received
a rating of severe or very severe (e.g., “seems sad or unhappy,”
“appears uneasy through the day”).
Relationships Among Parent-Report
Measures of Psychiatric Symptoms,
Emotion Dysregulation, IQ, Adaptive
Functioning, Maladaptive Behaviors, and
Autism Severity
First, we examined correlations between cognitive functioning
(NVIQ) and severity scores for the CASI-5 classifications and
the EDI factors. NVIQ was significantly negatively correlated
with CASI-5 T- scores only for symptoms of ADHD (for ADHD
Hyperactivity-impulsive type, r(64) = −0.381, p = 0.002, and
r(64) = −0.274, p = 0.024 for ADHD Combined type). No
other psychiatric comorbidities rated on the CASI-5 correlated
significantly with NVIQ. On the EDI, neither the reactivity nor
the dysphoria factors were correlated with NVIQ. However,
TABLE 4 | Mean (and Standard Deviations) of CASI-5 severity scores (T-scores)
for symptom classifications.
Child Adolescent p*
Mean (SD) Mean (SD)
DISRUPTIVE BEHAVIOR DISORDERS
ADHD
Inattentive type 67.85 (14.86) 63.75 (12.31) 0.01
Hyperactive/impulsive type 62.12 (10.72) 69.19 (11.17) ns
Combined type 67.0 (13.58) 67.8 (12.82) ns
Oppositional defiant disorder 45.24 (5.96) 47.09 (11.21) ns
Conduct disorder 46.82 (2.8) 48.84 (7.38) ns
ANXIETY DISORDERS
Generalized anxiety disorder 57.24 (9.06) 58.13 (10.9) ns
Separation anxiety disorder 50.18 (8.69) 57.59 (16.67) ns
MOOD DISORDERS
Major depressive episode 52.06 (9.89) 61.97 (13.63) 0.015
Dysthymic disorder 53.23 (10.05) 61.47 (15.67) ns
*Pairwise comparisons among estimated marginal means, controlling for NVIQ.
TABLE 5 | Means (and Standard Deviations) of T-scores on EDI factors by
age-group.
Child Adolescent p*
Mean (SD) Mean (SD)
EMOTION DYSREGULATION (EDI)
Reactivitya 41.91 (4.94) 43.65 (6.51) ns
Dysphoriaa 42.13 (4.96) 43.93 (6.30) ns
aT-scores. *Pairwise comparisons between estimated marginal means, controlling for
NVIQ.
because the two age groups differed significantly in NVIQ scores,
we conducted all other correlational analyses controlling for
NVIQ. Adaptive functioning scores (VABS-II Adaptive Behavior
Composite scores) were not correlated with any CASI-5 severity
T-scores or with the EDI factors in our sample.
Next, we examined autism symptom severity scores as
related to measures of psychiatric comorbidities and emotion
dysregulation severity, controlling for NVIQ. We found no
significant correlations between T- scores on the CASI-5 or the
EDI factors and ADOS calibrated severity scores. To investigate
whether psychiatric comorbidities and emotion dysregulation
contributed to behavioral dysregulation as assessed by ratings
of maladaptive behaviors (i.e., internalizing and externalizing
behaviors) on the VABS-II, we examined correlations between
CASI-5 and EDI factors T-scores, and VABS-II indices of
internalizing and of externalizing behaviors, controlling for
NVIQ. We selected from the CASI-5 the symptom classifications
for which T-scores are provided for both children and
adolescents, and for which our sample showed elevated severity
(T scores > 65, cf. Table 3). Table 6 presents partial correlations
among our primary measures from the CASI-5 and the EDI, and
indices ofmaladaptive behavior from the VABS-II, controlling for
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NVIQ. As expected based on the theoretical model of emotion
dysregulation underlying the EDI, the reactivity factor index on
the EDI was significantly correlated with ratings of externalizing
behaviors on the VABS-II after controlling for cognitive ability,
rp(53) = 0.383, p = 0.006. The dysphoria factor, however, was
not significantly correlated with internalizing behaviors scores on
the VABS-II. While EDI reactivity and dysphoria T-scores were
both correlated with the number of clinically significant CASI-
5 symptom classifications (a measure of “psychiatric burden”),
only the EDI dysphoria factor was significantly correlated with
the generalized anxiety CASI-5 classification, rp(54)= 0.398, p=
0.002, after adjusting for multiple testing (Table 6).
Finally, we were interested in exploring to what extent the
burden of psychiatric comorbidities and emotion dysregulation
predicted caregivers’ ratings of maladaptive behaviors in their
children, as reported on the VABS-II maladaptive behavior index.
To this end, we conducted a stepwise multiple regression analysis
entering chronological age and NVIQ on the first step, followed
by entering the two EDI factors (dysphoria and reactivity) and
the total number of clinically significant symptom classifications
from CASI-5 on the second step. Because neither the ASD
symptom severity calibrated score, nor the overall adaptive
functioning measure (VABS-II Adaptive Behavior Composite)
were correlated with any of the psychiatric comorbidity or
emotion dysregulation T- scores in our sample, we did not
enter these variables in the analysis. Results revealed that, when
entered in stepwise fashion, only the number of comorbid
symptom classifications on the CASI-5 was retained as predictor,
explaining 9.5% of variance in the VABS-II maladaptive index
scores [adjusted R2 = 0.095; F1,50 = 5.22. p= 0.027], whereas the
EDI factors did not make a significant contribution to the model
(EDI reactivity β = 0.125, t = 0.829, ns, and EDI dysphoria β =
−0.092, t=−0.610, ns).
DISCUSSION
In this first study of a relatively large and never hospitalized
outpatient sample of minimally verbal children and adolescents
with ASD, our main goal was to investigate co-occurring
psychiatric symptoms using several different measures
to provide a comprehensive phenotypic characterization
of MV individuals as related to psychiatric and emotion
dysregulation symptomatology. We found high rates of
psychiatric symptomatology on the CASI-5, but relatively low
rates of emotional dysregulation, especially dysphoria on the
EDI. We also found that the number of different psychiatric
symptom classifications endorsed on the CASI-5 was a key
predictor of maladaptive behavior. The overall picture to
emerge from this study is that minimally verbal children and
adolescents present with extremely heterogeneous profiles of
co-morbid psychopathology that are not easily predicted by
autism symptom severity, intellectual disability, or limitations
in communication.
Our main analyses focused on the CASI-5, a well-validated
parent-report psychiatric screening measure. Perhaps the most
striking finding was that virtually every participant met cut-off
criteria for at least one co-morbid condition, and the average
number of different co-morbidities across the sample was six.
The most common conditions included tics and phobias and
among psychiatric categories, ADHD was the most common. In
contrast, we found low rates of oppositional defiant disorder and
conduct disorder, perhaps reflecting the limited opportunities for
exhibiting signs of these disorders in the population we studied,
or caregivers’ construal of their children’s behavior. In general,
our findings are consistent with other reports in the literature.
In particular, the pattern of psychopathology we found matches
what Lerner and his colleagues reported (29) in their sample of
minimally verbal youth with ASD, although the rates that we
found were lower. This is not surprising since our sample had
never been hospitalized whereas Lerner et al.’s minimally verbal
participants were drawn largely from a current inpatient sample.
Finally, we note that on the CASI-5, as well as our other measures
of co-morbid psychopathology, we found very few differences
between children and adolescents. Rates of different disorders as
well as the number of different conditions were similar across
the sample. We also did not find differences between males and
females, although the small number of females who provided data
in this study precludes drawing valid conclusions about gender-
related similarities or differences in the profile of psychiatric
comorbidities of MV individuals with ASD.
Our second key measure for assessing psychopathology in
this study was the newly developed instrument, the EDI. This
measure, which taps two different emotion dysregulation factors,
reactivity and dysphoria, was specifically designed for and
normed on an ASD sample (35, 36). In contrast to the significant
psychopathology reported on the CASI-5, we found relatively
low rates of clinically significant dysregulation compared to
the instrument norms, with rates for dysphoria especially low.
One reason for our lower rates might again be related to
the difference in our sample since Mazefsky and colleagues
normed the EDI on a large sample of both inpatient and
outpatient children and adolescents with ASD and included both
verbal and minimally verbal individuals. Since rates of certain
co-morbid psychopathological conditions, particularly anxiety,
depression and ODD are significantly more prevalent among
more verbal individuals, and the EDI is correlated with CASI-
5 psychopathology, it is likely that our EDI findings reflect the
lower end of the ASD distribution of scores on this instrument.
A second explanation for the lower EDI scores in our sample
may be that parents either have trouble discerning the internal
emotional states of their minimally verbal children, or that they
interpret their child’s behavior and affect more in terms of their
primary diagnosis of ASD coupled with their severely limited
communicative abilities. Thus, if a child cannot say, for example,
they are unhappy or do not want to go to school, parents fail
to interpret behaviors that are consistent with these emotional
states in this way and therefore do not endorse those items
on the EDI.
We investigated the relationship between comorbid
psychopathology and other behavioral characteristics, including
non-verbal IQ, adaptive functioning, and autism symptom
severity. Among minimally verbal children and adolescents,
autism severity scores were not related to any of our measures of
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TABLE 6 | Partial correlations between severity scores for selected psychiatric symptom classifications (CASI-5), emotion dysregulation (EDI) factors, and maladaptive
behavior (VABS-II), controlling for cognitive ability (NVIQ).
VABS-II internalizing
behavior
VABS-II externalizing
behavior
EDI reactivity EDI dysphoria Number of comorbid
symptoms
ADHD inattentive type 0.202 0.269 0.060 0.267 0.440*
ADHD hyperactive /impulsive type 0.113 0.474* 0.214 0.181 0.425*
ADHD combined type 0.186 0.385* 0.129 0.274 0.472*
Generalized anxiety disorder 0.284 0.342 0.298 0.398* 0.577**
Major depressive disorder −0.228 −0.056 0.209 0.302 0.342*
Number of comorbid symptoms 0.245 0.244 0.407* 441*
EDI Dysphoria 0.100 0.076 0.554**
EDI Reactivity 0.079 0.383*
Significance level after Holm-Bonferroni correction: *p < 0.001; **p < 0.0001.
psychopathology and even IQ and adaptive behavior scores were
either not related or only to a modest degree (with r-values all
below 0.4). The lack of correlations between CASI-5 scores and
a general measure of adaptive functioning (VABS-II composite
scores) may seem surprising, in light of findings from other
research that documented associations between co-occurring
psychopathology and adaptive behavior in individuals with ASD
(32, 46, 47). However, these findings were based primarily on
samples of individuals with ASD without intellectual disabilities
(46, 48–51) or on mixed samples including both individuals
with IQ in the average range and those with ID, but whether
the mixed samples included MV-ASD participants remained
unspecified [see (52) for a review]. In the few studies that focused
on individuals with ASD and ID (53, 54) researchers examined
primarily associations between psychiatric comorbidities and
“problem behaviors” that directly impact adaptive functioning.
In our MV-ASD sample we also found expected associations
between psychiatric burden tapped by CASI-5 scores, the
Dysregulation factor of the EDI and maladaptive behaviors on
the VABS-II.
Consistent with the underlying model for the EDI, we found
correlations between the CASI-5 and the EDI. Both EDI factors
correlated significantly with most of the CASI-5 symptom
classifications severity scores and with the overall number of
different CASI-5 symptom classifications endorsed by each
respondent. Nevertheless, in our regression analysis exploring
which variables were the strongest concurrent predictors of
overall maladaptive behavior, only the number of different
CASI-5 symptom classifications accounted for 9.5% of the
variance; Although this is not a large portion of the variance,
it was significant in the context of model tested, whereas no
other predictor variables, including any of the EDI factors,
was significant. In some respect then, the number of different
symptom classifications may function as a cumulative risk
index for maladaptive behavior. Future research should explore
further whether models of this cumulative risk of co-morbid
psychopathology for minimally verbal individuals with ASD
would be more sensitive if certain comorbid conditions were
weighted higher than others were, but this would require a
significantly larger sample of individuals than we had available.
It would also be important to begin exploring whether there are
other factors that may protect some children and adolescents
from higher levels of maladaptive behavior, despite carrying a
significant burden of co-morbid psychopathology.
There are some notable limitations to this study.
Most importantly, we relied exclusively on parent report
questionnaires, which are generally less accurate than either in-
depth caregiver interviews or direct observation and evaluation
of psychiatric conditions. Since minimally verbal individuals
are, by definition, not able to report on their own feelings and
behavior, even a direct evaluation would depend largely on
parent report coupled with observations in a clinical setting. Still,
our findings may have been enhanced had they been coupled
with such observations carried out by an expert clinician. We
focused here specifically on an outpatient group of minimally
verbal children and adolescents, thus complementing the
work reported by Lerner and his colleagues (26; see also 33).
Because of the nature of the larger lab-based research study
in which the participants were enrolled, we excluded those
with the most severe behavior problems including aggression,
self-injury or non-compliance, and therefore our findings
must be viewed in the context of whom our participants
represent. Nevertheless, this study is an important step forward
in work that characterizes the minimally verbal end of the
autism spectrum who have so often been excluded from earlier
studies (cf. 24).
In sum, our study highlights the wide-ranging profiles of
comorbid psychopathology and degree of maladaptive behavior
among minimally verbal children and adolescents with ASD.
The findings do not suggest that the presence of these
comorbidities represent a subtype within the ASD population;
on the contrary, comorbid psychopathology is the norm rather
than the exception. This suggests that beginning at an early
age every minimally verbal person with ASD should have
ongoing clinical diagnostic and treatment services that focus
on these comorbid conditions, which may well change over
time within each child. It is likely that the burden of care for
minimally verbal people is related as much to their comorbid
conditions, including both the absence of functional language
and psychopathology. As we work toward including this end of
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the spectrum into our fuller understanding of ASD, we need to
embrace the highly complex and unique behavioral profiles of
each individual.
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